BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 30149689)

  • 1. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RP11-79H23.3 Inhibits the Proliferation and Metastasis of Non-small-cell Lung Cancer Through Promoting miR-29c.
    Liu M; Liu C; Li X; Li S
    Biochem Genet; 2023 Apr; 61(2):506-520. PubMed ID: 35972581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury.
    Gu S; Xie R; Liu X; Shou J; Gu W; Che X
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b.
    Xie P; Cao H; Li Y; Wang J; Cui Z
    Cancer Biomark; 2017 Dec; 21(1):123-133. PubMed ID: 29036788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA TP73‑AS1 promotes colorectal cancer proliferation by acting as a ceRNA for miR‑103 to regulate PTEN expression.
    Jia Z; Peng J; Yang Z; Chen J; Liu L; Luo D; He P
    Gene; 2019 Feb; 685():222-229. PubMed ID: 30472379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
    Li RK; Gao J; Guo LH; Huang GQ; Luo WH
    Cancer Gene Ther; 2017 Jul; 24(7):309-315. PubMed ID: 28731027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
    Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
    J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.
    Zhang R; Guo Y; Ma Z; Ma G; Xue Q; Li F; Liu L
    Oncotarget; 2017 Apr; 8(16):26079-26089. PubMed ID: 28212532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.
    Wang F; Luo Y; Zhang L; Younis M; Yuan L
    Cancer Gene Ther; 2022 Mar; 29(3-4):292-303. PubMed ID: 33707625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
    Li Z; Hong S; Liu Z
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
    Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
    Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
    Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
    Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
    Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.